Cargando…
Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience
The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant eff...
Autores principales: | Lüscher, Bernhard, Möhler, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544078/ https://www.ncbi.nlm.nih.gov/pubmed/31275559 http://dx.doi.org/10.12688/f1000research.18758.1 |
Ejemplares similares
-
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
por: Reddy, Doodipala Samba, et al.
Publicado: (2023) -
Efficacy of brexanolone in postpartum depression
por: Rodríguez Mercado, C. M.
Publicado: (2023) -
Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021) -
Overview of the Molecular Steps in Steroidogenesis of the GABAergic
Neurosteroids Allopregnanolone and Pregnanolone
por: Liang, Jennifer J., et al.
Publicado: (2018) -
A Vindication
por: Roy, G. C.
Publicado: (1882)